Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.
Public ClinicalTrials.gov record NCT00775398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multicenter, Open-Label, Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® (Thrombin, Topical U.S.P [Bovine Origin]) on Coagulation Parameters
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effect of possible exposure to THROMBIN JMI® on activated partial thromboplastin time (aPTT) at 48 hours post surgery in subjects with likelihood of prior exposure to THROMBIN JMI® within the past 4 years.
Study identification
- NCT ID
- NCT00775398
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 553 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Nov 2009 (Actual)
- Last update posted
- Jun 7, 2012
2008 – 2009
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Arcadia | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Pasadena | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Melbourne | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Fort Wayne | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Muncie | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Salisbury | Maryland | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Grand Blanc | Michigan | — | — |
| Not listed | Royal Oak | Michigan | — | — |
| Not listed | Saginaw | Michigan | — | — |
| Not listed | Jackson | Mississippi | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Hackensack | New Jersey | — | — |
| Not listed | Manhasset | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Chapel Hill | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Sewickley | Pennsylvania | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Temple | Texas | — | — |
| Not listed | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00775398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2012 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00775398 live on ClinicalTrials.gov.